Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 21, 2008. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) under Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding insider trading activity rather than a financial performance report.
Material Changes
The filing details a specific transaction involving Dr. M. Slaoui, a Person Discharging Managerial Responsibility. On February 20, 2008, a connected person of Dr. Slaoui sold 280 ordinary shares of GlaxoSmithKline plc at a price of GBP 11.40 per share. This sale was executed to meet tax liabilities following the vesting of a Performance Share Plan award.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly a notification of the share transaction described above.
Key Facts for Investor Verification
- Transaction Date: February 20, 2008
- Individual Involved: Dr. M. Slaoui (via a connected person)
- Transaction Type: Sale of 280 ordinary shares
- Price per Share: GBP 11.40
- Purpose: To meet tax liabilities from a Performance Share Plan vesting
- Notification Date: February 21, 2008